Thermo Fisher shareholders reject pay
What happened
- Thermo Fisher Scientific shareholders on May 20, 2026 re-elected all 11 directors but rejected the company’s advisory resolution on executive compensation, according to an SEC filing. - Thermo Fisher’s 2026 proxy said shareholders were asked to approve named executive officer pay, while the board recommended a vote in favor. (sec.gov) - Thermo Fisher said final vote results for the May 20 annual meeting are disclosed in its Form 8-K filed May 26. (sec.gov)
Why it matters
Thermo Fisher Scientific shareholders re-elected the company’s full board at the annual meeting on May 20, 2026, but voted down the advisory resolution on executive compensation, according to a Form 8-K filed with the U.S. Securities and Exchange Commission on May 26. The vote does not directly change pay because “say-on-pay” resolutions are nonbinding under U.S. securities rules, but it puts the company’s compensation program under fresh scrutiny ahead of its next proxy season. (sec.gov) Thermo Fisher’s board had recommended that investors support the pay proposal in its 2026 proxy statement. (sec.gov) The Waltham, Massachusetts-based company had also scheduled its 2026 Investor Day for May 20, the same day as the annual meeting, according to its investor relations website. Thermo Fisher says it generates more than $45 billion in annual revenue and employs more than 120,000 people. ### What exactly did shareholders vote against? Thermo Fisher’s May 26 Form 8-K said shareholders voted on multiple proposals at the May 20 annual meeting, including director elections and the advisory vote on executive compensation. The filing said all director nominees were elected for one-year terms expiring at the 2027 annual meeting, while the compensation proposal failed to win shareholder support. (sec.gov) The 2026 proxy statement asked investors to approve, on an advisory basis, the compensation of the company’s named executive officers. The board told shareholders it recommended a vote “for” each of its proposals, including the pay resolution. (ir.thermofisher.com) ### Why does a failed say-on-pay vote matter if it is nonbinding? U.S. public companies must periodically put executive compensation to an advisory shareholder vote under SEC proxy rules. A failed vote does not automatically force a company to cut pay or rewrite awards, but it is a visible signal that a company’s largest investors are dissatisfied with either the level of compensation, the structure of awards, or the company’s explanation of them in the proxy. (sec.gov) That inference is based on how say-on-pay votes are used in U.S. corporate governance practice; Thermo Fisher did not state in the 8-K why investors opposed the proposal. (sec.gov) ### What was Thermo Fisher asking investors to endorse this year? Thermo Fisher’s 2026 proxy statement described the company’s executive compensation program in its Compensation Discussion and Analysis and asked shareholders to approve the pay of its named executive officers. The filing framed 2025 as a year of “excellent operational performance,” saying revenue rose 4% to $44.56 billion, GAAP diluted earnings per share increased 7% to $17.74, and adjusted EPS rose 5% to $22.87. A January 12, 2026 Form 8-K also disclosed leadership changes, saying Marc N. (sec.gov) Casper would become chairman and chief executive officer effective March 1, 2026. The same filing said Michel Lagarde and Frederick M. Lowery had notified the company that they would leave to pursue other opportunities. ### What happens next for Thermo Fisher? Thermo Fisher is not required by the failed vote to take a specific pay action immediately, but companies that lose say-on-pay support typically address the result in the following year’s proxy statement and in shareholder outreach. (sec.gov) Any response by Thermo Fisher would most likely appear in its next annual proxy filing with the SEC. That is an inference based on standard disclosure practice; the company’s May 26 filing did not outline next steps. Thermo Fisher’s next formal milestones are likely to come through SEC filings and investor materials posted on its investor relations site, which lists the 2026 proxy statement, additional soliciting materials and annual meeting materials. (sec.gov) The next annual shareholder vote is scheduled for 2027, when directors elected on May 20, 2026 will stand again for one-year terms. (ir.thermofisher.com) (sec.gov)
Key numbers
- Thermo Fisher Scientific shareholders on May 20, 2026 re-elected all 11 directors but rejected the company’s advisory resolution on executive compensation, according to an SEC filing.
- Thermo Fisher’s 2026 proxy said shareholders were asked to approve named executive officer pay, while the board recommended a vote in favor.
- (sec.gov) Thermo Fisher said final vote results for the May 20 annual meeting are disclosed in its Form 8-K filed May 26.
- (sec.gov) Thermo Fisher Scientific shareholders re-elected the company’s full board at the annual meeting on May 20, 2026, but voted down the advisory resolution on executive compensation, according to a Form 8-K filed with the U.S.
What happens next
- Thermo Fisher Scientific shareholders re-elected the company’s full board at the annual meeting on May 20, 2026, but voted down the advisory resolution on executive compensation, according to a Form 8-K filed with the U.S.
- Securities and Exchange Commission on May 26.
- securities rules, but it puts the company’s compensation program under fresh scrutiny ahead of its next proxy season.
Quick answers
What happened in Thermo Fisher shareholders reject pay?
Thermo Fisher Scientific shareholders on May 20, 2026 re-elected all 11 directors but rejected the company’s advisory resolution on executive compensation, according to an SEC filing. Thermo Fisher’s 2026 proxy said shareholders were asked to approve named executive officer pay, while the board recommended a vote in favor. (sec.gov) Thermo Fisher said final vote results for the May 20 annual meeting are disclosed in its Form 8-K filed May 26. (sec.gov)
Why does Thermo Fisher shareholders reject pay matter?
Thermo Fisher Scientific shareholders re-elected the company’s full board at the annual meeting on May 20, 2026, but voted down the advisory resolution on executive compensation, according to a Form 8-K filed with the U.S. Securities and Exchange Commission on May 26. The vote does not directly change pay because “say-on-pay” resolutions are nonbinding under U.S. securities rules, but it puts the company’s compensation program under fresh scrutiny ahead of its next proxy season. (sec.gov) Thermo Fisher’s board had recommended that investors support the pay proposal in its 2026 proxy statement. (sec.gov) The Waltham, Massachusetts-based company had also scheduled its 2026 Investor Day for May 20, the same day as the annual meeting, according to its investor relations website. Thermo Fisher says it generates more than $45 billion in annual revenue and employs more than 120,000 people. What exactly did shareholders vote against? Thermo Fisher’s May 26 Form 8-K said shareholders voted on multiple proposals at the May 20 annual meeting, including director elections and the advisory vote on executive compensation. The filing said all director nominees were elected for one-year terms expiring at the 2027 annual meeting, while the compensation proposal failed to win shareholder support. (sec.gov) The 2026 proxy statement asked investors to approve, on an advisory basis, the compensation of the company’s named executive officers. The board told shareholders it recommended a vote “for” each of its proposals, including the pay resolution. (ir.thermofisher.com) Why does a failed say-on-pay vote matter if it is nonbinding? U.S. public companies must periodically put executive compensation to an advisory shareholder vote under SEC proxy rules. A failed vote does not automatically force a company to cut pay or rewrite awards, but it is a visible signal that a company’s largest investors are dissatisfied with either the level of compensation, the structure of awards, or the company’s explanation of them in the proxy. (sec.gov) That inference is based on how say-on-pay votes are used in U.S. corporate governance practice; Thermo Fisher did not state in the 8-K why investors opposed the proposal. (sec.gov) What was Thermo Fisher asking investors to endorse this year? Thermo Fisher’s 2026 proxy statement described the company’s executive compensation program in its Compensation Discussion and Analysis and asked shareholders to approve the pay of its named executive officers. The filing framed 2025 as a year of “excellent operational performance,” saying revenue rose 4% to $44.56 billion, GAAP diluted earnings per share increased 7% to $17.74, and adjusted EPS rose 5% to $22.87. A January 12, 2026 Form 8-K also disclosed leadership changes, saying Marc N. (sec.gov) Casper would become chairman and chief executive officer effective March 1, 2026. The same filing said Michel Lagarde and Frederick M. Lowery had notified the company that they would leave to pursue other opportunities. What happens next for Thermo Fisher? Thermo Fisher is not required by the failed vote to take a specific pay action immediately, but companies that lose say-on-pay support typically address the result in the following year’s proxy statement and in shareholder outreach. (sec.gov) Any response by Thermo Fisher would most likely appear in its next annual proxy filing with the SEC. That is an inference based on standard disclosure practice; the company’s May 26 filing did not outline next steps. Thermo Fisher’s next formal milestones are likely to come through SEC filings and investor materials posted on its investor relations site, which lists the 2026 proxy statement, additional soliciting materials and annual meeting materials. (sec.gov) The next annual shareholder vote is scheduled for 2027, when directors elected on May 20, 2026 will stand again for one-year terms. (ir.thermofisher.com) (sec.gov)
